Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Bernstein Downgrades Lam Research to Market Perform

Bernstein Downgrades Lam Research to Market Perform

Bernstein analyst Stacy Rasgon downgrades Lam Research (NASDAQ:LRCX) from Outperform to Market Perform.

byBenzinga Newsdesk

March 13, 2023

1 minute read

Bernstein analyst Stacy Rasgon downgrades Lam Research (NASDAQ:LRCX) from Outperform to Market Perform.

Analyst Ratings

Peeling Back The Layers: Exploring Plains GP Holdings Through Analyst Insights

By Benzinga Insights

April 12, 11:01 AM

In the preceding three months, 4 analysts have released ratings for Plains GP Holdings (NASDAQ:PAGP), presenting a wide…

PAGP

Story Cannabis Company To Acquire 4 Vertically Integrated Nature’s Medicines Dispensaries In Phoenix

By Maureen Meehan

August 2, 12:51 PM

Story Cannabis Company, an emerging player in the fast-growing cannabis industry, announced the acquisition of four vertically integrated cannabis licenses, currently branded under the name Nature’s Medicines, located in Arizona.

CSE:HARV

What’s Going On With AMD Stock?

By Anusuya Lahiri

December 28, 12:29 PM

Advanced Micro Devices, Inc (NASDAQ: AMD) stock is trading higher Thursday as enterprises including Big Techs like Amazon.Com Inc

AMD

HV Bancorp Q2 EPS $0.31 Down From $0.63 YoY

By Benzinga Newsdesk

August 5, 4:40 PM

HV Bancorp (NASDAQ:HVBC) reported quarterly earnings of $0.31 per share. This is a 50.79 percent decrease over earnings of $0.63 per share from the same period last year.

HVBC

Bernstein Downgrades Lam Research to Market Perform

Related Posts

Peeling Back The Layers: Exploring Plains GP Holdings Through Analyst Insights

Story Cannabis Company To Acquire 4 Vertically Integrated Nature’s Medicines Dispensaries In Phoenix

What’s Going On With AMD Stock?

HV Bancorp Q2 EPS $0.31 Down From $0.63 YoY